Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo

Prostate cancer (PCa) is a leading cause of cancer-related morbidity and mortality in men globally. Despite improvements in the diagnosis and treatment of PCa, a significant proportion of patients with high-risk localized disease and all patients with advanced disease at diagnosis will experience pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yehya, Amani, Ghamlouche, Fatima, Zahwe, Amin, Zeid, Yousef, Wakimian, Kevork, Mukherji, Deborah, Abou-Kheir, Wassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511807/
https://www.ncbi.nlm.nih.gov/pubmed/36176747
http://dx.doi.org/10.20517/cdr.2022.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511807/
https://www.ncbi.nlm.nih.gov/pubmed/36176747
http://dx.doi.org/10.20517/cdr.2022.15

Ejemplares similares